Clinical Trials Run Longer Than They Have To. That's a Patient Problem

USE CASE
Clinical Trial Operations Intelligence & Site Performance

Clinical trials are among the most resource-intensive and time-sensitive processes in any industry. The average Phase III trial now takes several years to complete. Each month of timeline extension represents significant cost, and more importantly, delayed access to a treatment for the patients who need it.

And yet, clinical operations functions frequently operate with a 2-4 week lag in their visibility into site-level performance issues. Enrollment velocity data arrives on a monthly cycle. Protocol deviation rates are reviewed in quarterly site assessments. By the time a performance problem at a site is identified, diagnosed, and addressed, weeks of additional timeline impact have already accumulated.

The Site Performance Visibility Problem

A VP of Clinical Operations managing a global multi-site trial cannot personally review site performance at the granularity that early intervention requires. The clinical data management systems contain the relevant data: enrollment records, protocol deviations, query response times, data entry completeness rates. What's missing is the ability to interrogate that data with the speed and specificity that operational management demands.

The site that's going to miss its enrollment target in Q3 was showing the warning signs in Q1. The question is whether anyone was looking at the right data with the right frequency.

Genie for Clinical Trial Intelligence

Databricks Genie enables clinical operations leaders to interrogate their full trial data environment in natural language. A VP of Clinical Operations can ask: 'Which sites in the Phase II oncology trial have screen failure rates greater than 40% over the past 60 days, and how does their enrollment pace compare to the original site activation target?' That question surfaces from your actual clinical data systems.

Timeline Intelligence as Patient Impact

Clinical trial timeline compression is a patient access issue as much as it is a commercial one. The VP of Clinical Operations who can identify and address performance problems weeks earlier, because they have faster, more fluent access to their trial data, is shortening the path from trial completion to treatment approval. That's the real value of operational data intelligence in life sciences.

DATABRICKS GENIE · KEY DIFFERENTIATORS
Built for your data, governed by your rules, answerable to any business leader.

• Multi-system integration: CTMS, EDC, safety databases, and site performance data in a unified analytical environment.
• Site comparison analysis: Genie can surface site-level outliers automatically — not just answer individual site questions.
• Regulatory-audit ready: Every Genie answer is traceable to source data records — important for GCP documentation requirements.
• Protocol-aware reasoning: Genie understands your protocol's specific endpoints, inclusion/exclusion criteria, and visit schedule in the context of data questions.

See What Genie Can Do for Your Team

Databricks Genie is available today. See how your industry peers are using it to reimagine how they access and act on their data.